Literature DB >> 15578504

The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance.

Akihiro Tajima1, Martin T Hess, Betty L Cabrera, Richard D Kolodner, John M Carethers.   

Abstract

BACKGROUND & AIMS: Recent evidence suggests that patients with advanced microsatellite unstable (MSI) colorectal cancers lack a survival benefit with 5-fluorouracil (5-FU)-based chemotherapy. Additionally, tumor cells with MSI (caused by defective DNA mismatch repair) are more resistant to 5-FU in culture compared with microsatellite stable cells, despite similar amounts of 5-FU incorporation into the cell's DNA. We examined whether the component of the DNA mismatch repair (MMR) system that normally recognizes single base pair mismatches could specifically recognize 5-FU incorporated into DNA as a potential mechanism for chemosensitivity.
METHODS: We synthesized oligonucleotides with and without incorporated 5-FU and created oligonucleotides with a single base pair mismatch (as a positive control) to perform electromobility gel shift assays (EMSA) with a purified, baculovirus-synthesized hMutS alpha MMR complex. We also utilized surface plasmon resonance to measure relative binding differences between the oligonucleotides and hMutS alpha in real time.
RESULTS: Using EMSA, we demonstrate that hMutS alpha recognizes and binds 5-FU-modified DNA. The reaction is specific as added ATP dissociates the hMutS alpha complex from the 5-FU-modified strand. Using surface plasmon resonance, we demonstrate greater binding between hMutS alpha and 5-FU-modified DNA compared with complementary DNA or DNA containing a C/T mismatch.
CONCLUSIONS: The MMR complex hMutS alpha specifically recognizes and binds to 5-FU-modified DNA. Because MMR components are required for the induction of apoptosis by many DNA-damaging agents, the chemosensitivity of 5-FU for patients with advanced colorectal cancer may be in part due to recognition of 5-FU incorporated into tumor DNA by the MMR proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15578504     DOI: 10.1053/j.gastro.2004.10.001

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  62 in total

1.  GRG Profiles: John M. Carethers.

Authors:  John M Carethers
Journal:  Dig Dis Sci       Date:  2016-06       Impact factor: 3.199

2.  Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.

Authors:  John M Carethers
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

3.  Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.

Authors:  J M Carethers
Journal:  Gut       Date:  2006-12       Impact factor: 23.059

4.  Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.

Authors:  J M Carethers
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

5.  Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.

Authors:  C Lamberti; S Lundin; M Bogdanow; C Pagenstecher; N Friedrichs; R Büttner; T Sauerbruch
Journal:  Int J Colorectal Dis       Date:  2006-05-25       Impact factor: 2.571

6.  A commentary on the article "Prevalence of the mismatch repair-deficient phenotype in colonic adenomas arising in HNPCC patients--results of a 5-year follow-up study".

Authors:  S Lassmann; M Werner
Journal:  Int J Colorectal Dis       Date:  2006-02-09       Impact factor: 2.571

7.  DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells.

Authors:  Moriya Iwaizumi; Stephanie Tseng-Rogenski; John M Carethers
Journal:  Cancer Biol Ther       Date:  2011-10-15       Impact factor: 4.742

8.  Gene expression variations in microsatellite stable and unstable colon cancer cells.

Authors:  Marjun P Duldulao; Wendy Lee; Maithao Le; Zhenbin Chen; Wenyan Li; Jinhui Wang; Harry Gao; Haiquing Li; Joseph Kim; Julio Garcia-Aguilar
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

Review 9.  Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

Authors:  Jung Ho Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

10.  Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.

Authors:  R Jover; P Zapater; A Castells; X Llor; M Andreu; J Cubiella; V Piñol; R M Xicola; L Bujanda; J M Reñé; J Clofent; X Bessa; J D Morillas; D Nicolás-Pérez; A Payá; C Alenda
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.